A new veterinary charity is offering veterinary surgeons, nurses and others in the profession the chance to get fit and raise money for Hounds for Heroes, SPANA and the Pet Blood Bank later this year.
The Vet Charity Challenge (VCC) is looking for teams to take part in a one-day event, involving a series of physical tasks and puzzle-solving challenges along the way, so it requires a bit of brain as well as brawn. The course will feature walking / running, cycling and kayaking and anyone can take part at whatever fitness level.
As well as raising money for the charities, organisers say it will be a fun way to build up camaraderie among your colleagues outside of the work environment and also a local PR opportunity for your practice or business to enhance your community profile.
The event is expecting to raise in excess of £30,000 for charity, but organisers stress that it will need the support of and participation by the veterinary profession to ensure it is a success.
The challenge will take place on Saturday 15th September 2012 at the Royal Agricultural College, Cirencester and all details may be found on http://www.vetcharitychallenge.co.uk/. Alternatively, ring 01727 859259 for further information. The VCC says an early commitment to take part is essential and the fine detail of training can be worked out later. The VCC will provide training guidelines and help you and your team prepare itself.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets 2 and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
The RCVS has clarified its role concerning new UK veterinary schools, saying that it has no mandate to control student or graduate numbers.
Responding to calls from the profession that it should comment on the desirability of any change in the number of schools or graduates, the College has confirmed that whilst it is committed to setting, upholding and advancing the standards that any new UK veterinary degrees would need to meet in order to be approved by the Privy Council, it has no role in capping student numbers.
The College also points out that the free market and mobility of workers in the EU makes any control at the level of a sovereign state effectively meaningless with respect to workforce management. However, the College says it is committed to ensuring that standards are maintained, and to continue working with bodies such as the European Association of Establishments for Veterinary Education, which evaluates veterinary degrees across Europe.
The College also seeks to support healthy debate through providing information on the state of the profession - an example of which is the survey that it recently commissioned from the Institute for Employment Studies on job availability for veterinary graduates over the last five years.
The headline results from that survey were released in the summer, and showed that increasing graduate numbers over the last five years have so far appeared to have had little impact on veterinary job prospects, with 94% of graduate respondents seeking a role in clinical practice obtaining work within six months of starting to look.
The full RCVS Survey of Recent Graduates report is now available, and also shows that, of the 43% of veterinary surgeons who graduated in the last five years who responded:
The answers were analysed by year of graduation, veterinary school, age and gender, and the full report is available online at www.rcvs.org.uk/publications.
Hysolv Animal Health UK has announced that it is offering a free diagnostic test which allows vets to identify the E. coli sub-types that produce the Shiga toxin associated with oedema disease in pigs.
The test, known as STEC-Check and worth £150-£200, is being sponsored by IDT Biologika GmbH. In the UK and Republic of Ireland, faeces and/or intestinal samples will be sent to the Animal Health and Plant Agency (APHA), Weybridge and SAC Consulting Veterinary Services at Penicuik to confirm results within a few days.
Hysolv says the test will provide a quick and accurate diagnosis, enabling appropriate action, including vaccination, to be taken on the farm.
Richard Brealey from Hysolv said: "Oedema disease is not always obvious and may be masked or controlled by the use of antibiotics, the use of zinc oxide or low-protein feeds which can also negatively affect productivity. This test will help confirm the presence of Shiga-toxin producing E. coli on the farm, a cause of serious losses in individual herds. We are therefore advising farmers to contact their vets to discuss using STEC-check on their farms."
According to the company, a nationwide study in Germany showed that 59% of farms where oedema was suspected were affected by Shiga toxin.
Richard added: "The Ecoporc Shiga vaccine has been recently licensed for use in the UK. There is pressure on vets and farmers to reduce the use of antimicrobials and vaccination, together with other measures, and this will help them to do this."
In the UK farmers will be able to carry out a DIY calculation of their return on investment online, using their smartphones or by visiting the Shiga toxin website www.shigatoxin.com
Four separate studies are included in the collection, reporting novel risk factors for the disease, identifying key differences between EGS and botulism (questioning the hypothesis that EGS is caused by neurotoxins from Clostridium botulinum), reporting a novel diagnostic technique and showing the value of monitoring weight loss to help predict whether individual horses with chronic EGS are likely to survive.
The publishers say that despite more than 100 years of research, supported predominantly by the The Moredun Foundation Equine Grass Sickness Fund (www.grasssickness.org.uk), the cause of EGS remains unknown. Since it almost exclusively affects grazing horses, a pasture derived neurotoxin is implicated. EGS causes gut paralysis as a result of damage to parts of the nervous system that control involuntary functions. Acute and sub-acute EGS is invariably fatal while around 55% of chronic cases can survive and return to a useful working life. The UK has the highest incidence of EGS in the world; indeed it is estimated that the disease kills between 1 and 2% of horses in the United Kingdom annually. Cases are more common in spring.
In terms of risk factors, the study ‘Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors’ suggests that the high incidence of the disease in Eastern Scotland may be partly associated with the particular composition of macro and trace elements in the soil in the fields on which horses graze. Further work is required to determine whether interventions to alter concentrations of particular elements in soil could potentially reduce the risk of EGS.1
A second study identified key differences between EGS and botulism, which questions the currently favoured hypothesis that EGS is caused by neurotoxins from Clostridium botulinum, a bacterium which commonly inhabits soil. The study ‘Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya’ suggests that EGS is unlikely to be caused by neurotoxins from this bacterium and concludes that further investigation of an alternative cause for EGS is needed.2
While the majority of horses with EGS can be readily diagnosed by experienced veterinary surgeons, some cases present a diagnostic challenge. Indeed the only way to definitively diagnose the disease in a live horse is to demonstrate the characteristic degeneration of nerves within biopsies of the intestine. Unfortunately these biopsies can only be collected by performing abdominal surgery under general anaesthesia. In the study ‘Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness’ characteristic degeneration of nerves was identified in small biopsies collected from tongues of EGS horses during post mortem examination. Examination of these biopsies accurately differentiated control horses from EGS cases. While further validation of this technique is required, it could potentially provide a relatively non-invasive method of confirming the diagnosis in a live horse.3
While around 55% of horses with chronic EGS survive, objective criteria for predicting survival of these cases are currently lacking. The study ‘Bodyweight change aids prediction of survival in chronic equine grass sickness’ reported that non-survivors had greater rate and magnitude of bodyweight loss than survivors. Survival prediction curves were published to allow veterinary surgeons and horse owners to use body weight data to help determine whether an individual horse with chronic EGS was likely to survive or die.4
Professor Bruce McGorum, Head of the Equine Section at the Royal (Dick) School of Veterinary Studies & Roslin Institute in Edinburgh, has been leading much of the research. He said: "Given that our recent research suggests that EGS is unlikely to be caused by neurotoxins from Clostridium botulinum we are now moving on to determine whether EGS is caused by ingestion of mycotoxins produced by pasture fungi. We are very pleased that The Horse Trust (www.horsetrust.org.uk) has provided funding for this three-year investigation."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: “While the cause of equine grass sickness continues to evade us, these papers present an optimistic step in the right direction for the eventual prevention of this dreadful disease. It is only with the support of the Moredun Foundation Equine Grass Sickness Fund and more recently that of The Horse Trust that our world-leading veterinary researchers are able to continue to unravel the mystery.”
The EVJ equine grass sickness collection can be downloaded at http://bit.ly/2dC7Drr
References
For the study, titled “RHDV2 epidemic in UK pet rabbits. Part 1: clinical features, gross post mortem and histopathological findings”1, veterinary surgeons were encouraged to submit case histories and the results of post mortem examinations of pet rabbits that died suddenly. Samples taken during the post mortem were sent for histopathological examination.
Frances Harcourt-Brown, corresponding author for the paper, said: "Case histories, macroscopic findings and histopathology results were available from 300 rabbits that died suddenly.
"Of these, 185 (62%) died from RHD and showed characteristic histopathological features of RHD including apoptosis and variable lytic and coagulative hepatocellular necrosis, with varying distribution.
"Interestingly, macroscopic evidence of disease was not present in all cases – for example, gross liver abnormalities were only reported in 30% of cases, despite all cases showing hepatocellular necrosis on microscopic examination.
"Rapid death and death of other rabbits in the household were common features of RHD.
"Histopathology was also useful in yielding valuable information about other causes of death in the rabbits that did not die from RHD.”
Nicola Di Girolamo, editor of JSAP said: “This is a terrible disease that is currently spreading in areas of the world that were free from it until recently. Having more evidence on the type of clinical presentations and lesions that should be expected with this disease in rabbit patients is going to be of tremendous value for clinicians. Given that there is not always macroscopic evidence of RHD, histopathology is key for the diagnosis of RHD in pet rabbits.”
The full article can be found in the July issue of the Journal of Small Animal Practice which is free for BSAVA members.
It can also be read online here: https://www.onlinelibrary.wiley.com/doi/full/10.1111/jsap.13141
Reference
Photo: BSAVA
Ceva introduced eco-friendly CLAS (Ceva Layered Anti Shatter) vials in 2007 and continues to invest in the technology for livestock injectables, such as NSAIDs and antibiotics.
However, the three-minute survey - https://www.surveymonkey.co.uk/r/CLASvials - will help it better understand current attitudes towards packaging and how it can continue to make changes that will drive improvements across the industry.
Five participating vets’ names will be picked at random to win a £20 Amazon voucher in a prize draw.
Peter Keyte, ruminant business unit manager at Ceva Animal Health said: “Following discussions with both UK vets and farmers, we believe that there is some confusion around the disposal of pharmaceutical waste both on farm and from the vet clinic.
"The survey will give us an insight into what is happening to pharmaceutical waste on farms and help us to drive improvements across the industry.”
Horiba Medical has announced the addition of the Dr. Fritz Video-Compact-System for veterinary endoscopic applications to its range of animal healthcare products. According to the company, the system is suitable for everyday small animal practice and includes a base unit and video otoscope attachment with a range of accessories for various applications.
Both the 1/3" CCD video camera and cold light source are combined in one solid and easy to operate unit, whilst the single cable technology enables the transfer of clear, magnified endoscopic images to the monitor. The camera can also be used independent of the light source and combined with a standard microscope to display urine, haematological and cytological slides. The single cable technology is facilitated by the TWIN Lock connection which enables the cable to be connected to the endoscopes with a secure bayonet lock. Offering high mobility and flexibility during examinations, the single cable makes the examination of agitated and moving animals easier.
The Dr. Fritz Video-Compact-System includes a complete set of equipment for all otoscopic examinations. The 90° video otoscope attachment can be combined with six different examination sheaths, permitting the examination of ears, oral cavity and teeth. The combined suction and irrigation sheath enables the flushing of inflammation from the ear under visual control prior to topical treatment. Horiba says that with the working sheath, removal of foreign objects, biopsy and even dental examinations of smaller animals such as rodents is much faster, easier and more secure when following the enhanced visual display.
Optional endoscopes are also available for the Dr. Fritz Video-Compact-System, expanding the possible applications by adding rhinoscopic, bronchoscopic, cystoscopic and gynaecological functionality.
Horiba will be exhibiting the Dr. Fritz Video-Compact-System at the London Vet Show at Olympia, 22nd to 23rd October 2010, on Stand M4.
The RCVS Disciplinary Committee has dismissed a case against a Nottinghamshire veterinary surgeon, having found not proven the charge that he had caused, allowed or failed to prevent a potential breach of the Rules of Racing of the Greyhound Board of Great Britain (GBGB).
During the re-scheduled, three-day hearing, the Committee heard that Dr Gary Samuel was on duty on 10 October 2009 as the GBGB licensed track veterinary surgeon at Nottingham Greyhound Stadium. When the trainer came to collect her dog for the race, she discovered a biscuit in his kennel in the paddock area, in potential contravention of the rules of the GBGB, which do not allow greyhounds access to any food, drink or other substance after weighing in, prior to a race. She reported this discovery to the paddock steward. The dog was withdrawn from the race, so there was no prospect of prize money. The trainer, despite her unblemished record, was put at risk of disciplinary action by the GBGB, which could have resulted in the loss of her training licence and livelihood. Following the events of 10 October, the GBGB held a disciplinary hearing, at which Dr Samuel was disqualified indefinitely from holding a GBGB licence and fined £2,500, and the matter was referred to the College.
The RCVS Disciplinary Committee confirmed that it should not be bound by the GBGB decision, and that the charges laid against Dr Samuel must be resolved on the basis of the evidence before it. Both Counsel for Dr Samuel and the College urged the Committee to have close regard of CCTV footage from 10 October, which showed Kennel 21 where the dog had been placed and the biscuit found. From evidence given by the paddock steward and the trainer, the Committee accepted that the kennel was clean when the dog entered at 5.30pm, so the biscuit must have been introduced between 5.30pm and 9pm, when the trainer collected him for the race.
The footage available to the Committee from Nottingham Race Track was only four-and-a-half minutes long. The Committee was concerned that there were almost three-and-a-half hours of footage that it had not been shown and that, in addition, witnesses were not able to state that they had viewed the remainder of the footage. In those circumstances, the Committee considered that the footage available must be of the best quality to allow it to reach a sure conclusion as to what exactly Dr Samuel may have been doing in his position close to Kennel 21. From the quality of the footage available, the Committee was not able to be sure.
Speaking on behalf of the Disciplinary Committee, Vice-Chairman Professor Sheila Crispin said: "The fact remains that the Committee cannot be sure that the Respondent caused the biscuit to enter Kennel 21, [so] finds the charge against the Respondent not proved."
Dr Samuel therefore remains on the RCVS Register and is entitled to practise.
MSD Animal Health has reintroduced Zanil, the flukicide drench for cattle and sheep.
Based on the active ingredient oxyclozanide, MSD says Zanil is highly effective against the adult fluke responsible for chronic disease and - significantly for dairy farmers - is licensed for use in young, pregnant and lactating animals, with a 72-hour milk withhold period where milk is produced for human consumption.
MSD Animal Health veterinary advisor Matt Haslam said: "The latest independent data1 confirms that fluke is on the increase in UK cattle and sheep. The fluke problem is longstanding, but is being exacerbated by recent wet summer and autumn periods that have created ideal conditions for this parasite to proliferate and infect grazing livestock.
"Chronic liver fluke causes serious economic losses for livestock farmers. In dairy herds, for example, there will be a negative impact on fertility and milk production where cows are affected.
"It is important that farmers have access to the best treatment options given the size of the threat and the scale of potential losses. Zanil is used widely and effectively in Ireland in the control of fluke problems, and there is no known resistance to the active ingredient oxyclozanide. With its re-introduction into the country, we believe Zanil is unique as a flukicide-only treatment that is licensed for use in lactation and in the dry period for the treatment of adult fluke in dairy cows."
Zanil is an oral drench with POM-VPS authorisation, available from both animal health suppliers and veterinary practices. Dosage rate is 3ml per 10kg bodyweight in cattle, up to a maximum of 105ml, and 4.5ml per 10kg bodyweight in sheep, up to a maximum of 20ml.
See DEFRA emerging threats reports in sheep and cattle, Q1 2013: www.defra.gov.uk/ahvla-en/files/pub-survrep-sr0113.pdf
MSD Animal Health's equine division has launched a new series of materials to support its Keeping Britain's Horses Healthy Campaign.
For veterinary practices, there's a Vet Reception Pack designed to help receptionists educate owners why they should vaccinate and the benefits of preventive healthcare.
For yards, there are posters giving guidance and advice on prevention of Infectious Respiratory Disease and the steps which should be taken to control a potential outbreak. They can be tailor made for an individual yard.
Peter Young, MSD Animal Health Equine Business Manager said: "Our first wave of support materials focused very much on equine vets and owners - helping raise awareness of the importance of preventive healthcare and driving owners towards vets for advice. This phase of materials helps support yard owners and receptionists, aiming to fill some of those communications gaps where advice and guidelines on individual horse's vaccination requirements and yard protocols can play a vital role in preventing the spread of disease and controlling outbreaks."
Keeping Britain's Horses Healthy is a national campaign to educate horse owners on endemic infectious disease, vaccination, herd immunity and the importance of preventative healthcare. It includes a range of educational materials for veterinary surgeries and direct to owners. The campaign is supported by a national PR, advertising and social media programme, together with a dedicated website www.healthyhorses.co.uk. The website, aimed at driving owners back to their veterinary practices, includes a vet finder, exclusively for equine practices, and healthcare information.
For full details of the launch programme, talk to your account manager, call 01908 685685 or visit www.healthyhorses.co.uk.
Orthomed has announced the launch of a series of four webinars covering a range of orthopaedic subjects.
The webinars are being presented by global diplomates and hosted by The Webinar Vet. They are:
Orthomed says the presentations are suitable for orthopaedic surgeons of all levels and interests, as well as those looking to get more involved in orthopaedic surgery.
The webinars are being held monthly, starting at the end of March.
The webinar series costs £97, which includes a £150 voucher to redeem against an Orthomed workshop.
In addition, the Webinar Vet has made 15 tickets available free of charge. To see if you can claim one, email Orthomed at info@orthomed.co.uk with the subject title Orthopaedic Webinar.
For more information, visit: https://www.thewebinarvet.com/orthopaedicexpertise
The investment is being made to increase the speed at which concerns are either closed or referred, ensure that the process meets its service standards and reduce stress for the public and profession.
The decision to increase investment in the process was made by the College’s Operational Board in response to a steady increase in the number of concerns being investigated. The College forecasts that it will receive in excess of 1,000 concerns raised about the professional conduct of veterinary surgeons and veterinary nurses this year.
The RCVS developed a simplified, three-stage concerns process in 2014 which included the introduction of targets for cases to be either closed or referred at each stage. In order to ensure that these targets can be met, the College will now be hiring five paralegals to assist the existing five case managers.
Eleanor Ferguson, Acting Registrar, said: "Currently we are only closing or referring just over half of concerns we receive at stage 1 (case examiner stage) within our four month target. In order for the system to run more smoothly we will be investing in extra staff to help clear the backlog and ensure that these targets are met going forward.
"Similarly, in order to deal with the increase in the number of cases being referred to Preliminary Investigation Committee (stage 2), we will be increasing the frequency of these committee meetings from one to two per month.
"It is important to add that this investment is not just about dealing with concerns more quickly but is also about quality of service and having more staff on hand will ensure that this quality is maintained in terms of how we communicate with complainants and members of the profession. Speeding up the process will reduce the stress and anxiety felt by all involved."
More details about the College’s concerns investigation process and its different stages can be found at www.rcvs.org.uk/concerns
The company says it estimates that 75% of its staff have periods and many will find themselves caught short without a pad or tampon when they have an earlier or heavier period than expected.
This can be very embarrassing and stressful, so tampon/towel dispensing machines are being installed in the loos at every CVS veterinary practice and site in the UK.
Helen Finney, Group HR Director at CVS, said: “We want to provide dignity and peace of mind for all of the colleagues who work at CVS.
"We wouldn't expect colleagues to have to bring their own toilet paper to work.
"So those who experience periods shouldn't fear being caught short either.
"In a busy practice it can be difficult to ask a colleague if they have a tampon or towel, or to find time to go out to buy supplies.
“By providing free period products to colleagues while at work, we are seeking to help in one small but meaningful way.”
When one stops to think about this (albeit as the male editor of a veterinary website), it is something of a wonder that it has taken this long. Helen's quote about loo paper hits the nail on the head. Why do all work loos not have period products by default?
Sanofi-aventis and Merck & Co., Inc. announced today that Sanofi-aventis has exercised its option to combine Merial with Intervet/Schering-Plough, Merck's Animal Health business.
The new joint venture will be equally-owned by Merck and Sanofi-aventis. The formation of this new joint venture is subject to execution of final agreements, antitrust review in the United States, Europe and other countries, and other customary closing conditions. The completion of the transaction is expected to occur in approximately the next 12 months.
Richard T. Clark, Merck Chairman, President and Chief Executive Officer said: "Merck has been in the animal health business for well over six decades and through this new joint venture, we will bolster our diverse portfolio and create a new global competitor poised for growth.
"This new joint venture delivers on Merck's commitment to customer focus by creating one of the broadest portfolios of animal health products and services in pharmaceuticals and biologics for millions of customers who include farmers, veterinarians and pet owners. The planned joint venture will have an attractive geographical network of global technology and expertise to provide health solutions based on customers' needs, which often vary regionally."
The worldwide animal health market reached $19 billion in 2008. Products for companion animals accounted for 40 percent of total sales while products for production animals accounted for the remaining 60 percent of total sales. This market is expected to grow at around 5 percent per year over the next 5 years, driven by a growing demand for animal proteins, as well as a strong consumer needs for companion animal health care.
The companies said that both Merial and Intervet/Schering-Plough will continue to operate independently until the closing of the transaction.
The BVA is now reaching out to non-members with a three-month, no strings attached, free trial. The offer ends on 31 August.
Over the past few years the BVA membership package has changed significantly in response to the needs of veterinary surgeons across the UK at all stages of their careers.
Harvey Locke, BVA President, said: "The well-documented stresses that put members of our profession at risk of mental health problems are unacceptably high. With their focus on conflict resolution and individual support, however, we hope the BVA legal services will come to be seen as a safety net for BVA members should things go wrong at work.
"These kinds of employment issues can be hard to talk about so we hope by highlighting a few stories it will encourage others to seek the help they need from the BVA.
"The three-month free trial is an opportunity for the BVA to reach out to non-members and show them the impact of our complete membership package - from the legal and employment services and free and discounted CPD to our popular publications and money-saving financial services."
The veterinary buying groups VetShare and London Vet Forum (LVF) have announced that they have merged to become the VetShare Buying Group.
VetShare Buying Group says that merger will ensure it has the resources and capabilities to compete in an industry that is increasingly made up of larger merged animal health suppliers.
The venture was prompted by a decision by London Vet Forum to offer itself up for a merger or sale with the aim of attracting better discounts for its members. It then interviewed a shortlist of candidates and says VetShare come out on top principally for its clarity and competitive discounts negotiated with the manufacturers.
In addition, VetShare and LVF shared some ways of working - members handle their own wholesaler invoice with the wholesaler-practice relationship remaining intact, allowing discounts to be rebated as a separate transaction. This means that members can continue to do business as before, while also benefiting from being part of the new, larger buying group.
Vet Ruth Gray, VetShare Director, said: "We are very pleased to have been chosen by the LVF directors to take their members into the future. We are the only major buying group without reps on the road and yet are now perhaps the largest buying group in the UK. We started VetShare initially to help our own practice achieve better discounts with the assumption that if we set up the perfect model for us then it would probably also be perfect for others. In hindsight, I think our assumption was right and this merger will mean even better discounts with new and exciting opportunities for existing members of both groups".
For more information on membership and the merged group, visit www.vetshare.co.uk or call Ruth on 0800 7566636.
The Department for Environment, Food and Rural Affairs (Defra) says this is evidence that its strategy to tackle bovine TB, which costs taxpayers £100m a year, is delivering results.
Defra says that gaining OTF status for the low risk area, covering the north and east of England, would boost trade opportunities and mean some herds require less regular TB testing, reducing costs for farmers.
This would be the first time anywhere in England has enjoyed this status and the government says it is a key step in its 25-year plan for the whole of the UK to be TB-free by 2038.
Environment Secretary Andrea Leadsom said: "Gaining global recognition that more than half of England is TB-free will be a significant milestone in our long-term plan to eradicate this devastating disease, and will open up new trading opportunities for farmers.
"We have much still to do in the worst affected parts of the country, but this shows that our strategy - combining practical biosecurity measures, a robust cattle movement and testing regime, and badger control in areas where the disease is rife - is right and is working."
Results published today confirm all ten licensed badger control operations achieved successful outcomes. A consultation opens today on next steps for badger control in areas that have completed the first four years of intensive culling.
Other measures announced today include:
Chief Veterinary Officer Nigel Gibbens said: "This year we have seen that badger control can be delivered successfully on a wider scale. Further expansion in the coming years, alongside our robust cattle movement and testing regime, will allow us to achieve and maintain long term reductions in the level of TB across the South West and Midlands where the disease is currently widespread."
The government says it is taking robust action to make the country TB-free by 2038, with a strategy including stronger cattle testing and movement controls, good biosecurity, badger control in areas where TB is rife and vaccination when possible.
Vaccinating healthy badgers is part of the government’s long-term plan and could play an important role in preventing bovine TB spreading to new areas of the country. Defra plans to resume the Badger Edge Vaccination Scheme, which offers support for private badger vaccination projects in edge area counties, in 2018 when we expect vaccine supplies to be available once more following the current global shortage.
The government is also supporting farmers to take practical action to reduce the risk of infection onto their farm. This includes support for a new CHeCS TB cattle herd accreditation scheme, on-farm biosecurity demonstrations for farmers, and training for veterinary surgeons delivered by APHA jointly with the private sector. Farmers can also access practical guidance on the TB Hub, which brings advice from farming experts, vets and government together in one place.
The webinar programme includes both clinical and non-clinical topics.
Clinical topics include post mortem/diagnostics and calf pneumonia, parasitology – getting the basics right, and herd health planning – vaccination on farm.
Non-clinical topics include business skills, motivational interviewing techniques – facilitating effective communication between farmers and vets, and cow signals.
Webinars take place on the last Wednesday of each month, except August and December when there are no sessions.
Each webinar lasts for one hour, including a live question and answer session with the presenter. Those who are unable to view the live webinar will be able to access the content at a later date, but will not be able to pose questions.
To access the webinars, you need to register on Merial’s Nexus portal (merialnexus.co.uk). If you sign up in advance for individual webinars, you'll get reminder emails before they start.
The study was a randomised controlled trial of client-owned dogs and cats presenting as emergencies and requiring intravenous catheterisation.
Patient signalment and mentation score were recorded.
Patients were randomly allocated to either a swab saturated with vapocoolant spray or a swab saturated with saline applied to the clipped area before intravenous catheterisation.
Indirect application of vapocoolant spray via a swab before catheterisation was not found to significantly reduce the reaction of dogs and cats, nor to improve placement success rates.
The study did demonstrate a significantly greater adverse response to vapocoolant spray application to the skin via a swab when compared with the saline control in canine patients; feline patients demonstrated adverse responses to both vapocoolant spray and saline swabs.
It is unclear if the technique of application used in this study provided sufficient cooling effect to provide the required cryoanaesthesia to influence patient reaction.
The authors say future studies should be used to determine optimal vapocoolant spray application technique in dogs and cats, as well as examine its application in other populations and procedures.
Nicola Di Girolamo, Editor of JSAP concluded: “Pragmatic, adequately-powered, randomised controlled trials like the one presented here are essential to evaluate whether an intervention is not only efficacious in a controlled environment, but also effective during clinical practice.”
Full article: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13504
Trinder, R, Humm, K, Phillips, S, and Cole, L (2022) The efficacy of vapocoolant spray for the improved tolerance of catheter pain in emergency patients in dogs Journal of Small Animal Practice, Available at: https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13504
Webinar Vet Anthony Chadwick MRCVS (pictured right) has launched the UK's first virtual CPD congress for veterinary surgeons.
The event will 18 hours of CPD lectures via two live streams and one recorded stream. Anthony said: "Covering topics such as endocrinology with Prof Ian Ramsey, diagnostic imaging with Prof Mike Herrtage, and feline internal medicine with Dr Jane Armstrong, delegates will be able to jump-start their 2013 CPD in the most effective and efficient way!"
All three streams will also be available after the congress. Anthony said: "We have put a great programme together with top speakers from the UK, Australia and the USA. All of the sessions are being recorded and you will have access to all of the webinar after the event. This means delegates can watch one stream on the day and then the other lectures at their leisure."
The Webinar Vet International Virtual Congress is being held on Saturday 12th January 2013, between 9:30 - 4:30 pm GMT. It is open to non-members as well as members, at £97+VAT and £37+VAT respectively. For more details on the 18 lectures and to buy a ticket, visit http://www.theinternationalwebinarvet.com
Vétoquinol - maker of Epiphen, the anti-epileptic phenobarbital for the control of epilepsy in dogs - has added a new client brochure and a fridge magnet to its Epiphen support packs, designed to help owners understand the condition and make it easier for them to comply with daily dosage requirements.
The new brochure is called What I need to know and is written for clients that have been prescribed Epiphen for their pet for the first time.
Abbie King, Product Manager for Epiphen, said: ''The inspiration for the new brochure came after spending time at the Animal Health Trust in Newmarket and realising how much information an owner needs to take in when their dog is diagnosed with epilepsy."
The new brochure covers the important information owners need to help them understand and manage their dog's epilepsy, including how Epiphen works, what they can do to help their dog, how to monitor seizures, where to find further information and frequently asked questions.
The Epiphen Treatment fridge magnet is designed as a quick reference guide to prescribing information that is needed every day when living with a dog with epilepsy. The magnet leaves space for the owner to write in their dog's name, dosage details and timings and their vet's phone number. Vétoquinol says it is especially helpful as a reference if more than one person is caring for the dog.
The new items enhance the existing Epiphen support pack, which comprises an owner manual, medication record and seizure diary, dog tags, seizure report pads, free serum level monitoring vouchers and a free, online resource at www.epiphenonline.co.uk
Vétoquinol also invites practitioners who are dealing with challenging cases to take advantage of its free Ask the expert scheme on 0800 169 8197 or email a case history to epiphen@vetoquinol.co.uk.
To order the new Epiphen support materials, ring 0800 1698197. Alternatively, visit: www.vetoquinol.co.uk to find out more.
Pfizer Animal Health has confirmed that the agreement to acquire multiple product franchises from the Schering-Plough Corporation has been completed - and approved by the European Commission. Pfizer has acquired these assets for approximately euro 116 million in cash.
The agreement covers all European Union countries and the franchises include all major animal health species including cattle, swine, equine and companion animal. Pfizer executives say the agreement leaves them with the most in-depth coverage of therapeutic areas, and the most highly recognised brands, in the industry. Precise details of the agreement are not being released although additional information on the products concerned will be the subject of further announcements in due course.
Pfizer has acquired certain rights to the following products in the European Economic Area:
Albert Bourla, President of Pfizer Animal Health in Europe, said: "This represents a significant expansion of our product portfolio and strengthens our long term commitment not just to veterinary surgeons, but also to farmers and pet owners. Pfizer spends hundreds of millions of dollars on research and development every year, and brings more new products to market than any other company, but when the opportunity arose to add well known, well respected brands to a portfolio that is already extremely strong, we had little hesitation in taking it."
CEVA Animal Health has extended its behavioural range of products with the launch of Senilife®, a nutritional supplement which is specifically formulated to help manage signs of brain ageing in dogs and cats.
Senilife® contains a combination of three essential brain nutrients - phosphatidylserine, vitamin B6 and vitamin E - which the company says help maintain membrane fluidity and normalise neurotransmission. In addition, two natural but potent anti-oxidants - gingko biloba and resveratrol - support brain metabolism and help to neutralise free radicals and reduce amyloid deposits.
According to CEVA, common signs of brain ageing in dogs and cats include playing or interacting less, barking or howling at night, loss of house-training/litter box training, apathy or increased tiredness and disorientation. A study has shown that up to 75% of dogs over seven years of age and 35% of cats 11 years and over suffer from at least one geriatric behavioural problem1.
In a recent clinical study, 86% of owners were satisfied with the results achieved after one month of using Senilife®, with 73% of dog owners and 67% of cat owners noticing fewer signs of brain ageing within the first seven days2.
Juliet Penaliggon, small animal marketing manager at CEVA Animal Health, says: "Many typical signs of brain ageing in dogs can be controlled by nutritional management. Senilife® is a fast-acting, nutritional supplement that contains proven nutrients and neuroprotectives to help manage these signs."Senilife® capsules are easy to administer either directly into the mouth of the pet or emptied onto the pet's food."
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
References1 Behaviour problems in geriatric pets. Lansberg G and Araujo J. Vet Clin North Am Small Anim Pract. 35 (2005) 675-698.2 Isaka N, Baysse B, Lopez A, Ovaert P and Penaliggon J. CABSTG Spring Meeting April (2009).
Dorwest Herbs has launched its annual 'Dorwest Say Relax' fireworks phobia campaign, which includes free promotional packs for practices.
The promotional packs, which contain a poster, leaflets, flashing badges and a 'Dorwest Say Relax' t-shirt, being given free to the first 100 practices that request a product box (containing licensed Scullcap & Valerian Tablets and Organic Valerian Compound at a discounted price) from the company.
In addition, Dorwest is running a seemingly popular consumer facebook competition to find the most relaxed dog in the nation, the winner of which will be sent on a pet-friendly luxury weekend break.
Finally, the company is writing a blog written from the perspective of Merlin, the dog used in its logo - http://merlintakescontrol.wordpress.com - though quite who is going to read it, or why, is slightly beyond me.
Ceva Animal Health has launched a new TV advertising campaign to raise awareness of the benefits of the veterinary behavioural product, Feliway.
The new advertisement, features the new 'Feliway' purple cat playing happily in the home with its family.
The advertisement will appear on the major UK channels including More 4, E4, ITV 1, Sky Channels and the Discovery Channel for one week from 16th September 2013, with an additional three weeks coverage during October 2013. Behind the scenes' footage of the filming of the advertisement can also be viewed on the Feliway YouTube Channel: http://www.youtube.com/channel/UCtAXd5mReYc6JGufxRirvng?feature=watch
A Feliway video on demand and YouTube campaign will be available to viewers between 16th September 2013 and 21st October 2013 and will be repeated between 15th November 2013 and 2nd December 2013.
An Adaptil video on demand campaign will be aired between 21st October 2013 and 11th November 2013 to raise awareness of Adaptil in the run up to and during the firework season. The video on demand will be available across ITV player, Sky Anytime On Demand, 4oD and YouTube.
For more information, call 01494 781510 or contact your local Ceva territory manager.